ERp46 mitigates lipotoxic ER stress to preserve GLUT2 expression and insulin secretion in β-cells
Chen D., Chen X., Tian Y., Wang K., Han C.
Laboratory Study on Type 2 Diabetes, published in Biomed Rep (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Biomed Rep (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41384131
- PMCID
- PMC12690449
- DOI
- 10.3892/br.2025.2095
Abstract (original English)
Lipotoxicity-induced β-cell dysfunction is a critical contributor to the pathogenesis of type 2 diabetes mellitus. The aim of the present study was to investigate the role of endoplasmic reticulum-resident protein 46 (ERp46) in regulating glucose transporter 2 (GLUT2) expression and insulin secretion in β-cells under palmitic acid (PA)-induced lipotoxic stress. β-TC6 cells were treated with PA to induce lipotoxicity, and ERp46 expression was silenced using specific small interfering RNA. GLUT2 expression and insulin secretion were assessed, and the involvement of protein kinase B (AKT) signaling was evaluated. The results demonstrated that PA significantly decreased GLUT2 expression and insulin secretion, while ERp46 expression was upregulated as a potential compensatory response. ERp46 knockdown exacerbated the reduction of GLUT2 expression and insulin secretion. Furthermore, PA treatment reduced phosphorylated AKT (p-AKT) levels without altering total AKT expression, and ERp46 knockdown further decreased p-AKT levels. The activation of AKT using AKT activator compound SC79 restored GLUT2 expression and insulin secretion in ERp46-depleted cells. These findings indicated that ERp46 helps preserve β-cell function under lipotoxic stress, potentially by stabilizing ER proteostasis and supporting AKT phosphorylation.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol